BIO World Congress Announces New Education Track and Plenary Session on Food Ingredients and Personal CareMay 2 2017
The 2017 BIO World Congress on Industrial Biotechnology education program features seven diverse education tracks with speakers from around the world over three days of the conference.
|
|
BIO Statement on Release of USTR’s 2017 “Special 301 Report”May 1 2017
USTR’s 2017 report addresses many of the key IP-related challenges that BIO members face globally.
|
|
BIO Congratulates Sonny Perdue, U.S. Agriculture SecretaryApr 24 2017
Washington, D.C. (April 24, 2017) – The Biotechnology Innovation Organization (BIO) congratulates Sonny Perdue on his confirmation to be U.S. Agriculture Secretary. In bipartisan fashion, the Senate overwhelmingly approved Perdue by a vote of 87 to 11.
|
|
BIO Selects San Diego Industry Leaders For 2017 Convention Steering CommitteeApr 21 2017
The Biotechnology Innovation Organization (BIO) has announced the steering committee for its upcoming BIO 2017 International Convention, which will be held in downtown San Diego from June 19 to 22.
|
|
BIO Announces Educational Sessions for 2017 BIO World Congress on Industrial BiotechnologyApr 20 2017
Panels feature international speakers from renewable chemical and consumer product companies.
|
|
BIO Statement on MedPAC VoteApr 7 2017
Washington, DC (April 6, 2017) – The Biotechnology Innovation Organization (BIO) issued the following statement regarding today's Medicare Payment Advisory Commission (MedPAC) vote:
|
|
Congresswoman Sinema Honored as BIO Legislator of the YearApr 5 2017
Arizona Congresswoman Kyrsten Sinema was named a 2017 BIO Legislator of the Year
|
|
BIO Celebrates Five Years of the JOBS ActApr 5 2017
Today the Biotechnology Innovation Organization (BIO) celebrates the fifth anniversary of the Jumpstart Our Business Startups (JOBS) Act, which was signed into law on April 5, 2012.
|
|
BIO Brings Worldwide Life Sciences Community Back to San DiegoMar 23 2017
Registration Now Open for International Convention Set for June 19-22
|
|
Biotech Leader Testifies Before House Capital Markets SubcommitteeMar 22 2017
Washington, DC (March 22, 2017) – Brian Hahn, Chief Financial Officer of GlycoMimetics, Inc., provided testimony today on behalf of the Biotechnology Innovation Organization (BIO) before the House Subcommittee on Capital Markets and Government Sponsored Enterprises. Hahn serves as the Co-Chair of BIO’s Finance & Tax Committee.
|